Advertisement
Optimally timed valve replacement depends on an expert approach to nuanced presentations
Post hoc analysis of PROTECTED TAVR finds reduced stroke risk in the U.S. but not beyond
Large longitudinal study supports earlier intervention over clinical surveillance
Analysis of STS/ACC TVT Registry finds greatest benefit in patients with prior stroke
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Join us in New York Dec. 6-7 for broadened version of a CME crowd-pleaser
Questions remain following late mortality signal from a retrospective cohort study
TAVR explant demands multidisciplinary expertise
Judicious application yields a 99.7% repair rate and 0.04% mortality
Limited data and experience will translate to a cautious rollout
Cleveland Clinic series supports re-repair as a favored option regardless of failure timing
Advertisement
Advertisement